Viability-Indicating Compound for Precise Tissue Debridement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for surgical debridement lack precision in distinguishing between viable and nonviable tissue, leading to unnecessary removal of healthy tissue and delayed wound healing.
Innovation Solution
A method involving the use of a compound that differentiates between viable and nonviable cells, allowing for accurate identification and targeted removal of nonviable tissue, using formulations such as gels, sprays, or sheets with detectable markers like antibodies, aptamers, or dyes that visualize cell viability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional visual inspection methods are used for tissue debridement, then the surgical procedure is simple and quick, but the precision of distinguishing viable from nonviable tissue is poor leading to removal of healthy tissue
Solution Approach 1:
The patent introduces an indicator compound as an intermediary substance that mediates between the tissue and the surgeon's observation. The compound binds to specific tissue components (DNA, RNA, proteins) and produces visible color changes, enabling indirect detection of tissue viability through chemical-biological interactions rather than direct visual inspection.
Solution Approach 2:
The patent utilizes color changes as the primary detection mechanism. Different indicator compounds exhibit specific color responses when binding to viable versus nonviable tissue components - for example, certain dyes bind to denatured proteins in necrotic tissue producing distinct color patterns, while viable tissue shows different coloration, providing visual differentiation for precise debridement boundaries.
2Reliability
If aggressive debridement is performed to ensure removal of all nonviable tissue, then the confidence in complete necrotic tissue removal increases, but viable tissue is inadvertently removed reducing functional outcomes
Solution Approach 1:
The patent applies local quality differentiation by using indicator compounds that provide spatially resolved information about tissue viability. The color changes occur locally at specific tissue boundaries, allowing the surgeon to identify precise debridement margins zone by zone rather than applying uniform aggressive removal across the entire wound bed, thus preserving viable tissue while removing necrotic tissue.
Solution Approach 2:
The indicator compound system provides real-time visual feedback during the debridement process. As the surgeon removes tissue, the color changes continue to provide immediate information about the viability status of remaining tissue, allowing dynamic adjustment of debridement intensity and boundaries to maximize necrotic tissue removal while minimizing viable tissue loss.
3Measurement precision
If multiple debridement procedures are performed to gradually remove questionable tissue, then the risk of removing viable tissue is reduced, but the treatment time increases and wound healing is delayed
Solution Approach 1:
The patent applies preliminary action by applying the indicator compound to the tissue prior to making the final debridement decision. This pre-treatment staining or coloring process allows the surgeon to assess tissue viability in advance and plan the debridement boundaries with confidence, eliminating the need for multiple exploratory procedures and enabling complete debridement in a single operation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise debridement procedures, reducing the removal of viable tissue and enhancing wound healing outcomes by accurately identifying and removing nonviable cells, thereby improving surgical accuracy and patient recovery.
Implementation Method 1
the compound specifically binds to a molecule that has a differential expression pattern in viable vs. nonviable cells
Implementation Method 2
The compound further comprises a detectable marker
Data Source
AI summary
Provided are methods of determining whether a cell in a tissue site is viable or nonviable. Also provided are methods of debriding tissue from a tissue site. Further provided are kits comprising a compound that distinguishes between viable and nonviable cells and instructions for using the compound on a tissue site. Additionally, the use of a compound that distinguishes between viable and nonviable cells is provided, where the use is to determine whether a cell in a tissue site is viable or nonviable. Also provided is a use of a compound that distinguishes between viable and nonviable cells, where the use is for the manufacture of the above-described kit.